Cardiac Troponin I Concentration May Predict Mortality

THURSDAY, Aug. 10, 2023 (HealthDay News) -- Cardiac troponin I (cTnI) concentration is associated with medium-term mortality in an unselected hospital population, according to a study published online Aug. 7 in Heart.
Jonathan Hinton, from the University of Southampton in the United Kingdom, and colleagues conducted a prospective observational study including 20,000 consecutive in-hospital and outpatient patients who had a blood test for any reason at a large teaching hospital and in whom a high-sensitivity cTnI assay was measured.
Overall, 91.4 percent of the patients did not have a clinical indication for cTnI testing. The researchers found that 14.1 percent of patients died at a median of 809 days. If the cTnI concentration was above the upper limit of normal, mortality was significantly higher (45.3 versus 12.3 percent). In a multivariable analysis, log10 cTnI concentration was independently associated with mortality (hazard ratio, 1.76). The relationship persisted in a landmark analysis, excluding deaths within 30 days.
"These findings suggest that a snapshot cTn in a hospital population may represent a biomarker of overall medium-term mortality," the authors write.
One author disclosed ties to the biopharmaceutical industry.
Related Posts
Higher Neighborhood Walkability Tied to Lower Gestational Diabetes Risk
FRIDAY, Feb. 24, 2023 (HealthDay News) -- Higher neighborhood walkability is...
Monthly Injections Might Lower Bleeding in People With Hemophilia
FRIDAY, March 31, 2023 (HealthDay News) -- An experimental injectable drug...
Too Many Antibiotics Might Raise Colon Cancer Risk
THURSDAY, Sept. 2, 2021 (HealthDay News) -- Here's another reason to avoid...
Sharp Spike Seen in Air Pollution Levels in Recent Years
THURSDAY, April 21, 2022 (HealthDay News) -- After 23 years of decreases in...
